Complete downmodulation of P-selectin glycoprotein ligand in monocytes undergoing apoptosis
Jan-Julius Stampfuss1, Petra Censarek, Jens W Fischer
1Institut für Pharmakologie, Universität Duisburg-Essen, Universitätsklinikum Essen, Hufelandstr. 55, D-45122 Essen, Germany.
Objective:
Apoptotic monocytes release membrane microparticles which may play a major role in thrombogenicity through a P-selectin glycoprotein ligand (PGSL-1)-mediated mechanism. We have studied systematically the regulation of PSGL-1 expression and function in apoptotic monocytic cells.
Methods And Results:
PSGL-1 expression (flow cytometry, immunofluorescence microscopy, immunoblot) was virtually abolished in apoptotic monocytes by proteolytic shedding. This was accompanied by a complete loss of PSGL-1-mediated platelet-leukocyte (flow cytometry) and leukocyte-endothelial cell (parallel plate flow chamber) interactions. Systematic screening of protease inhibitors combined with knock-out and siRNA experiments characterized the PSGL-1-cleaving enzyme as an N-ethylmaleimide-inhibitable metalloproteinase of the ADAM family.
Conclusions:
Downmodulation of PGSL-1 in apoptotic monocytes may prevent ectopic cell clearance in the peripheral vasculature to reduce local inflammatory and proliferative responses. Depletion of PSGL-1 expression on apoptotic microparticles may also act as a molecular switch to modulate their thrombogenic activity.
Insights
Apoptotic monocytes shed P-selectin glycoprotein ligand-1 (PSGL-1), reducing cell interactions and thrombogenicity. This shedding is mediated by an ADAM metalloproteinase, suggesting a mechanism to control inflammation and clotting.
Area of Science:
- Cell Biology
- Immunology
- Hematology
Background:
- Apoptotic monocytes release microparticles implicated in thrombosis via P-selectin glycoprotein ligand-1 (PSGL-1).
- Understanding PSGL-1 regulation in apoptosis is crucial for its role in thrombogenicity.
Purpose of the Study:
- To systematically investigate the regulation of PSGL-1 expression and function in apoptotic monocytic cells.
- To identify the mechanism and enzyme responsible for PSGL-1 downmodulation during monocyte apoptosis.
Main Methods:
- Flow cytometry, immunofluorescence microscopy, and immunoblotting to assess PSGL-1 expression.
- Platelet-leukocyte and leukocyte-endothelial cell interaction assays.
- Protease inhibitor screening, knock-out, and siRNA experiments to identify the cleaving enzyme.
Main Results:
- PSGL-1 expression was significantly reduced in apoptotic monocytes due to proteolytic shedding.
- This shedding led to a complete loss of PSGL-1-mediated platelet-leukocyte and leukocyte-endothelial cell interactions.
- An ADAM metalloproteinase, inhibited by N-ethylmaleimide, was identified as the enzyme responsible for PSGL-1 cleavage.
Conclusions:
- Downregulation of PSGL-1 on apoptotic monocytes may prevent inappropriate cell clearance, reducing vascular inflammation and proliferation.
- PSGL-1 depletion on apoptotic microparticles may serve as a molecular switch modulating their thrombogenic potential.
More Related Videos
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Selectins
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
GPCR Desensitization


